26 September 2016 - Johnson & Johnson is considering commercialising two of the winning inventions from a hackathon earlier this month, which would result in faster rehabilitation for people who have had knee reconstructions, and better treatment outcomes for Alzheimer's sufferers.

Participants in the hackathon, which was run by the three Johnson & Johnson companies in Australia (Johnson & Johnson Pacific, Johnson & Johnson Medical and Janssen Pharmaceuticals) came from a variety of industries, including space engineering and robotics, but were predominantly university students.

Read Australian Financial Review article